| 000 | 01598 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516082158.0 | ||
| 264 | 0 | _c20120723 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0031990 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLam, Yu Ming Paul | |
| 245 | 0 | 0 |
_aSwitching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA. _h[electronic resource] |
| 260 |
_bPloS one _c2012 |
||
| 300 |
_ae31990 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDNA _xmetabolism |
| 650 | 0 | 4 |
_aDNA Primers _xgenetics |
| 650 | 0 | 4 |
_aDNA, Viral _xgenetics |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
| 650 | 0 | 4 | _aRaltegravir Potassium |
| 650 | 0 | 4 |
_aReal-Time Polymerase Chain Reaction _xmethods |
| 650 | 0 | 4 | _aTerminal Repeat Sequences |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aMcBride, Kristin L | |
| 700 | 1 | _aAmin, Janaki | |
| 700 | 1 | _aCordery, Damien V | |
| 700 | 1 | _aKelleher, Anthony D | |
| 700 | 1 | _aCooper, David A | |
| 700 | 1 | _aKoelsch, Kersten K | |
| 773 | 0 |
_tPloS one _gvol. 7 _gno. 3 _gp. e31990 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0031990 _zAvailable from publisher's website |
| 999 |
_c21602514 _d21602514 |
||